PMC:3586680 / 121-323 JSONTXT

{"project":"test3","denotations":[{"id":"T65","span":{"begin":180,"end":184},"obj":"Protein"},{"id":"T64","span":{"begin":173,"end":176},"obj":"Protein"},{"id":"T63","span":{"begin":167,"end":171},"obj":"Protein"},{"id":"T62","span":{"begin":131,"end":166},"obj":"Protein"},{"id":"T47","span":{"begin":180,"end":184},"obj":"Protein"},{"id":"T46","span":{"begin":173,"end":176},"obj":"Protein"},{"id":"T45","span":{"begin":167,"end":171},"obj":"Protein"},{"id":"T44","span":{"begin":131,"end":166},"obj":"Protein"}],"relations":[{"id":"R5","pred":"themeOf","subj":"T63","obj":"T64"},{"id":"R6","pred":"equivalentTo","subj":"T64","obj":"T62"}],"text":"tly mutated in glioblastomas (GBMs) and appears to contribute, in part, to resistance to temozolomide (TMZ) and therapeutic drugs. WW domain-containing oxidoreductase WWOX (FOR or WOX1) is a proapoptoti"}

{"project":"testone","denotations":[{"id":"T25","span":{"begin":180,"end":184},"obj":"Protein"},{"id":"T24","span":{"begin":173,"end":176},"obj":"Protein"},{"id":"T23","span":{"begin":167,"end":171},"obj":"Protein"},{"id":"T22","span":{"begin":131,"end":166},"obj":"Protein"}],"text":"tly mutated in glioblastomas (GBMs) and appears to contribute, in part, to resistance to temozolomide (TMZ) and therapeutic drugs. WW domain-containing oxidoreductase WWOX (FOR or WOX1) is a proapoptoti"}

{"project":"bionlp-st-ge-2016-test-tees","denotations":[{"id":"T479","span":{"begin":180,"end":184},"obj":"Protein"},{"id":"T478","span":{"begin":173,"end":176},"obj":"Protein"},{"id":"T477","span":{"begin":152,"end":171},"obj":"Protein"}],"text":"tly mutated in glioblastomas (GBMs) and appears to contribute, in part, to resistance to temozolomide (TMZ) and therapeutic drugs. WW domain-containing oxidoreductase WWOX (FOR or WOX1) is a proapoptoti"}

{"project":"bionlp-st-ge-2016-spacy-parsed","denotations":[{"id":"T603","span":{"begin":189,"end":190},"obj":"DT"},{"id":"T602","span":{"begin":186,"end":188},"obj":"VBZ"},{"id":"T601","span":{"begin":184,"end":185},"obj":"-RRB-"},{"id":"T600","span":{"begin":180,"end":184},"obj":"CD"},{"id":"T599","span":{"begin":177,"end":179},"obj":"CC"},{"id":"T598","span":{"begin":173,"end":176},"obj":"IN"},{"id":"T597","span":{"begin":172,"end":173},"obj":"-LRB-"},{"id":"T596","span":{"begin":167,"end":171},"obj":"NNP"},{"id":"T595","span":{"begin":152,"end":166},"obj":"NN"},{"id":"T594","span":{"begin":134,"end":151},"obj":"JJ"},{"id":"T593","span":{"begin":131,"end":133},"obj":"NNP"},{"id":"T592","span":{"begin":129,"end":130},"obj":"."},{"id":"T591","span":{"begin":124,"end":129},"obj":"NNS"},{"id":"T590","span":{"begin":112,"end":123},"obj":"JJ"},{"id":"T589","span":{"begin":108,"end":111},"obj":"CC"},{"id":"T588","span":{"begin":106,"end":107},"obj":"-RRB-"},{"id":"T587","span":{"begin":103,"end":106},"obj":"NNP"},{"id":"T586","span":{"begin":102,"end":103},"obj":"-LRB-"},{"id":"T585","span":{"begin":89,"end":101},"obj":"VB"},{"id":"T584","span":{"begin":86,"end":88},"obj":"TO"},{"id":"T583","span":{"begin":75,"end":85},"obj":"NN"},{"id":"T582","span":{"begin":72,"end":74},"obj":"TO"},{"id":"T581","span":{"begin":70,"end":71},"obj":","},{"id":"T580","span":{"begin":66,"end":70},"obj":"NN"},{"id":"T579","span":{"begin":63,"end":65},"obj":"IN"},{"id":"T578","span":{"begin":61,"end":62},"obj":","},{"id":"T577","span":{"begin":51,"end":61},"obj":"VB"},{"id":"T576","span":{"begin":48,"end":50},"obj":"TO"},{"id":"T575","span":{"begin":40,"end":47},"obj":"VBZ"},{"id":"T574","span":{"begin":36,"end":39},"obj":"CC"},{"id":"T573","span":{"begin":34,"end":35},"obj":"-RRB-"},{"id":"T572","span":{"begin":30,"end":34},"obj":"NNS"},{"id":"T571","span":{"begin":29,"end":30},"obj":"-LRB-"},{"id":"T570","span":{"begin":15,"end":28},"obj":"NNS"},{"id":"T569","span":{"begin":12,"end":14},"obj":"IN"},{"id":"T568","span":{"begin":4,"end":11},"obj":"VBN"}],"relations":[{"id":"R281","pred":"ROOT","subj":"T568","obj":"T568"},{"id":"R282","pred":"prep","subj":"T569","obj":"T568"},{"id":"R283","pred":"pobj","subj":"T570","obj":"T569"},{"id":"R284","pred":"punct","subj":"T571","obj":"T572"},{"id":"R285","pred":"appos","subj":"T572","obj":"T570"},{"id":"R286","pred":"punct","subj":"T573","obj":"T568"},{"id":"R287","pred":"cc","subj":"T574","obj":"T568"},{"id":"R288","pred":"conj","subj":"T575","obj":"T568"},{"id":"R289","pred":"aux","subj":"T576","obj":"T577"},{"id":"R290","pred":"xcomp","subj":"T577","obj":"T575"},{"id":"R291","pred":"punct","subj":"T578","obj":"T577"},{"id":"R292","pred":"prep","subj":"T579","obj":"T575"},{"id":"R293","pred":"pobj","subj":"T580","obj":"T579"},{"id":"R294","pred":"punct","subj":"T581","obj":"T575"},{"id":"R295","pred":"aux","subj":"T582","obj":"T583"},{"id":"R296","pred":"advcl","subj":"T583","obj":"T568"},{"id":"R297","pred":"aux","subj":"T584","obj":"T585"},{"id":"R298","pred":"advcl","subj":"T585","obj":"T583"},{"id":"R299","pred":"punct","subj":"T586","obj":"T587"},{"id":"R300","pred":"appos","subj":"T587","obj":"T585"},{"id":"R301","pred":"punct","subj":"T588","obj":"T587"},{"id":"R302","pred":"cc","subj":"T589","obj":"T585"},{"id":"R303","pred":"amod","subj":"T590","obj":"T591"},{"id":"R304","pred":"conj","subj":"T591","obj":"T585"},{"id":"R305","pred":"punct","subj":"T592","obj":"T568"},{"id":"R306","pred":"compound","subj":"T593","obj":"T596"},{"id":"R307","pred":"compound","subj":"T594","obj":"T596"},{"id":"R308","pred":"compound","subj":"T595","obj":"T596"},{"id":"R309","pred":"nsubj","subj":"T596","obj":"T602"},{"id":"R310","pred":"punct","subj":"T597","obj":"T598"},{"id":"R311","pred":"prep","subj":"T598","obj":"T596"},{"id":"R312","pred":"cc","subj":"T599","obj":"T598"},{"id":"R313","pred":"conj","subj":"T600","obj":"T598"},{"id":"R314","pred":"punct","subj":"T601","obj":"T598"},{"id":"R315","pred":"ROOT","subj":"T602","obj":"T602"}],"text":"tly mutated in glioblastomas (GBMs) and appears to contribute, in part, to resistance to temozolomide (TMZ) and therapeutic drugs. WW domain-containing oxidoreductase WWOX (FOR or WOX1) is a proapoptoti"}

{"project":"bionlp-st-ge-2016-test-ihmc","denotations":[{"id":"T537","span":{"begin":131,"end":166},"obj":"Protein"},{"id":"T535","span":{"begin":89,"end":107},"obj":"Entity"},{"id":"T534","span":{"begin":180,"end":184},"obj":"Protein"},{"id":"T532","span":{"begin":131,"end":171},"obj":"Protein"},{"id":"T526","span":{"begin":112,"end":129},"obj":"Entity"},{"id":"T523","span":{"begin":103,"end":106},"obj":"Entity"}],"text":"tly mutated in glioblastomas (GBMs) and appears to contribute, in part, to resistance to temozolomide (TMZ) and therapeutic drugs. WW domain-containing oxidoreductase WWOX (FOR or WOX1) is a proapoptoti"}

{"project":"DLUT931","denotations":[{"id":"T403","span":{"begin":180,"end":184},"obj":"Protein"},{"id":"T402","span":{"begin":173,"end":176},"obj":"Protein"},{"id":"T401","span":{"begin":167,"end":171},"obj":"Protein"},{"id":"T400","span":{"begin":131,"end":166},"obj":"Protein"}],"text":"tly mutated in glioblastomas (GBMs) and appears to contribute, in part, to resistance to temozolomide (TMZ) and therapeutic drugs. WW domain-containing oxidoreductase WWOX (FOR or WOX1) is a proapoptoti"}

{"project":"BioNLP16_Messiy","denotations":[{"id":"T453","span":{"begin":180,"end":184},"obj":"Protein"},{"id":"T452","span":{"begin":173,"end":176},"obj":"Protein"},{"id":"T451","span":{"begin":167,"end":171},"obj":"Protein"},{"id":"T450","span":{"begin":131,"end":166},"obj":"Protein"}],"text":"tly mutated in glioblastomas (GBMs) and appears to contribute, in part, to resistance to temozolomide (TMZ) and therapeutic drugs. WW domain-containing oxidoreductase WWOX (FOR or WOX1) is a proapoptoti"}

{"project":"BioNLP16_DUT","denotations":[{"id":"T361","span":{"begin":180,"end":184},"obj":"Protein"},{"id":"T360","span":{"begin":173,"end":176},"obj":"Protein"},{"id":"T359","span":{"begin":167,"end":171},"obj":"Protein"},{"id":"T358","span":{"begin":131,"end":166},"obj":"Protein"}],"text":"tly mutated in glioblastomas (GBMs) and appears to contribute, in part, to resistance to temozolomide (TMZ) and therapeutic drugs. WW domain-containing oxidoreductase WWOX (FOR or WOX1) is a proapoptoti"}

{"project":"bionlp-st-ge-2016-uniprot","denotations":[{"id":"T389","span":{"begin":180,"end":184},"obj":"http://www.uniprot.org/uniprot/Q9NZC7"},{"id":"T388","span":{"begin":173,"end":176},"obj":"http://www.uniprot.org/uniprot/Q9NZC7"},{"id":"T382","span":{"begin":167,"end":171},"obj":"http://www.uniprot.org/uniprot/Q9NZC7"}],"namespaces":[{"prefix":"_base","uri":"http://www.uniprot.org/uniprot/"}],"text":"tly mutated in glioblastomas (GBMs) and appears to contribute, in part, to resistance to temozolomide (TMZ) and therapeutic drugs. WW domain-containing oxidoreductase WWOX (FOR or WOX1) is a proapoptoti"}

{"project":"bionlp-st-ge-2016-test-proteins","denotations":[{"id":"T121","span":{"begin":131,"end":166},"obj":"Protein"},{"id":"T122","span":{"begin":167,"end":171},"obj":"Protein"},{"id":"T123","span":{"begin":173,"end":176},"obj":"Protein"},{"id":"T124","span":{"begin":180,"end":184},"obj":"Protein"}],"namespaces":[{"prefix":"_base","uri":"http://bionlp.dbcls.jp/ontology/ge.owl#"}],"text":"tly mutated in glioblastomas (GBMs) and appears to contribute, in part, to resistance to temozolomide (TMZ) and therapeutic drugs. WW domain-containing oxidoreductase WWOX (FOR or WOX1) is a proapoptoti"}

{"project":"pmc-enju-pas","denotations":[{"id":"T216","span":{"begin":189,"end":190},"obj":"DT"},{"id":"T215","span":{"begin":186,"end":188},"obj":"VB"},{"id":"T214","span":{"begin":184,"end":185},"obj":"-RRB-"},{"id":"T213","span":{"begin":180,"end":184},"obj":"NN"},{"id":"T212","span":{"begin":177,"end":179},"obj":"CC"},{"id":"T211","span":{"begin":173,"end":176},"obj":"NN"},{"id":"T210","span":{"begin":172,"end":173},"obj":"-LRB-"},{"id":"T209","span":{"begin":167,"end":171},"obj":"NN"},{"id":"T208","span":{"begin":152,"end":166},"obj":"NN"},{"id":"T207","span":{"begin":134,"end":151},"obj":"JJ"},{"id":"T206","span":{"begin":131,"end":133},"obj":"JJ"},{"id":"T205","span":{"begin":124,"end":129},"obj":"NN"},{"id":"T204","span":{"begin":112,"end":123},"obj":"JJ"},{"id":"T203","span":{"begin":108,"end":111},"obj":"CC"},{"id":"T202","span":{"begin":106,"end":107},"obj":"-RRB-"},{"id":"T201","span":{"begin":103,"end":106},"obj":"NN"},{"id":"T200","span":{"begin":102,"end":103},"obj":"-LRB-"},{"id":"T199","span":{"begin":89,"end":101},"obj":"NN"},{"id":"T198","span":{"begin":86,"end":88},"obj":"TO"},{"id":"T197","span":{"begin":75,"end":85},"obj":"NN"},{"id":"T196","span":{"begin":72,"end":74},"obj":"TO"},{"id":"T195","span":{"begin":70,"end":71},"obj":"-COMMA-"},{"id":"T194","span":{"begin":66,"end":70},"obj":"NN"},{"id":"T193","span":{"begin":63,"end":65},"obj":"IN"},{"id":"T192","span":{"begin":61,"end":62},"obj":"-COMMA-"},{"id":"T191","span":{"begin":51,"end":61},"obj":"VB"},{"id":"T190","span":{"begin":48,"end":50},"obj":"TO"},{"id":"T189","span":{"begin":40,"end":47},"obj":"VB"},{"id":"T188","span":{"begin":36,"end":39},"obj":"CC"},{"id":"T187","span":{"begin":34,"end":35},"obj":"-RRB-"},{"id":"T186","span":{"begin":30,"end":34},"obj":"NN"},{"id":"T185","span":{"begin":29,"end":30},"obj":"-LRB-"},{"id":"T184","span":{"begin":15,"end":28},"obj":"NN"},{"id":"T183","span":{"begin":12,"end":14},"obj":"IN"},{"id":"T182","span":{"begin":4,"end":11},"obj":"VB"}],"relations":[{"id":"R46","pred":"arg1Of","subj":"T182","obj":"T183"},{"id":"R47","pred":"arg1Of","subj":"T182","obj":"T188"},{"id":"R48","pred":"arg2Of","subj":"T184","obj":"T183"},{"id":"R49","pred":"arg1Of","subj":"T184","obj":"T185"},{"id":"R50","pred":"arg2Of","subj":"T186","obj":"T185"},{"id":"R51","pred":"arg3Of","subj":"T187","obj":"T185"},{"id":"R52","pred":"arg2Of","subj":"T189","obj":"T188"},{"id":"R53","pred":"arg2Of","subj":"T191","obj":"T189"},{"id":"R54","pred":"arg1Of","subj":"T191","obj":"T190"},{"id":"R55","pred":"arg1Of","subj":"T191","obj":"T192"},{"id":"R56","pred":"arg1Of","subj":"T191","obj":"T193"},{"id":"R57","pred":"arg1Of","subj":"T191","obj":"T195"},{"id":"R58","pred":"arg1Of","subj":"T191","obj":"T196"},{"id":"R59","pred":"arg2Of","subj":"T194","obj":"T193"},{"id":"R60","pred":"arg1Of","subj":"T197","obj":"T198"},{"id":"R61","pred":"arg1Of","subj":"T197","obj":"T203"},{"id":"R62","pred":"arg2Of","subj":"T199","obj":"T198"},{"id":"R63","pred":"arg1Of","subj":"T199","obj":"T200"},{"id":"R64","pred":"arg2Of","subj":"T201","obj":"T200"},{"id":"R65","pred":"arg3Of","subj":"T202","obj":"T200"},{"id":"R66","pred":"arg2Of","subj":"T203","obj":"T196"},{"id":"R67","pred":"arg2Of","subj":"T205","obj":"T203"},{"id":"R68","pred":"arg1Of","subj":"T205","obj":"T204"},{"id":"R69","pred":"arg1Of","subj":"T209","obj":"T206"},{"id":"R70","pred":"arg1Of","subj":"T209","obj":"T207"},{"id":"R71","pred":"arg1Of","subj":"T209","obj":"T208"},{"id":"R72","pred":"arg1Of","subj":"T209","obj":"T210"},{"id":"R73","pred":"arg1Of","subj":"T209","obj":"T215"},{"id":"R76","pred":"arg1Of","subj":"T211","obj":"T212"},{"id":"R77","pred":"arg2Of","subj":"T212","obj":"T210"},{"id":"R78","pred":"arg2Of","subj":"T213","obj":"T212"},{"id":"R79","pred":"arg3Of","subj":"T214","obj":"T210"}],"namespaces":[{"prefix":"_base","uri":"http://kmcs.nii.ac.jp/enju/"}],"text":"tly mutated in glioblastomas (GBMs) and appears to contribute, in part, to resistance to temozolomide (TMZ) and therapeutic drugs. WW domain-containing oxidoreductase WWOX (FOR or WOX1) is a proapoptoti"}

{"project":"simple1","denotations":[{"id":"T154","span":{"begin":180,"end":184},"obj":"Protein"},{"id":"T153","span":{"begin":173,"end":176},"obj":"Protein"},{"id":"T152","span":{"begin":167,"end":171},"obj":"Protein"},{"id":"T151","span":{"begin":131,"end":166},"obj":"Protein"}],"text":"tly mutated in glioblastomas (GBMs) and appears to contribute, in part, to resistance to temozolomide (TMZ) and therapeutic drugs. WW domain-containing oxidoreductase WWOX (FOR or WOX1) is a proapoptoti"}